Samalin Investment Counsel, LLC Viatris Inc Transaction History

Samalin Investment Counsel, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $16,089 - $19,840	-1,617 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $8,985 - $14,106	916 Added 130.67%	1,617 $17.6 Million
Q4 2021 Feb 15, 2022	SELL	$12.09 - $14.68 $16,055 - $19,495	-1,328 Reduced 65.45%	701 $9.48 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $185 - $211	14 Added 0.69%	2,029 $27.5 Million
Q2 2021 Aug 12, 2021	BUY	$12.97 - $16.15 $26,134 - $32,542	2,015 New	2,015 $28,000
Q1 2021 May 11, 2021	SELL	$13.59 - $18.54 $33,417 - $45,589	-2,459 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $35,163 - $46,081	2,459 New	2,459 $46.1 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.